Race against superbug: new drug combo enters final testing for deadly hospital pneumonia
Disease control
Not yet recruiting
This study is testing a new antibiotic combination (BV100 plus polymyxin B) against a standard treatment for a severe type of pneumonia caught in hospitals. It focuses on infections caused by a bacteria that resists most antibiotics, making them very hard to treat. The main goal …
Phase: PHASE3 • Sponsor: BioVersys SAS • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC